No woman no cry

20 Sep 2019

I wonder how often our thoughts are related to locating trading ideas lol

Anyway, CryoLife is a leader in the manufacture, processing and distribution of medical devices and implanted tissues used in cardiovascular surgery.
This week announced the signing of an agreement with Endospan. The agreement grants exclusive distribution rights of NEXUS (transplant system) and immediate access to the market that is considered most profitable in Europe. In addition, the deal also opens the possibility of acquiring Endospan in the future.
Has been moving for some time between 25.5-30.5 - and fails to take direction.
30.5 is a clear historical resistance level. Above it, we will consider a long play.

So… sometime it will ptobably return to the ups but for now it seems to be aiming back down, first target might be 28.
All of the above, of course, at your own discretion, your trading rules and your preferred trading strategies.
This is not a recommendation to buy / sell.
Goodluck..